Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Phoreus Biotechnology
AddedFeb 16, 2024
UpdatedJun 18, 2026
Phoreus Biotechnology

Phoreus Biotechnology

Seed

Phoreus Biotechnology, Inc.: Revolutionizing global One Health with proprietary peptide nanocarrier technology.

HQ
Olathe, KS, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Phoreus Biotechnology, Inc. was founded with the mission to revolutionize global One Health through its proprietary peptide nanocarrier technology. The company focuses on precision drug delivery, particularly for the next generation of genetic vaccines and therapeutics. Phoreus offers two main technology platforms: Branched Amphipathic Peptide Capsules®️ (BAPC®️) and Corralling Amphipathic Peptide Colloids™️️ (CAPC™️️), which significantly enhance the efficacy of targeted, precision delivery systems.

Notable affiliated individuals and investors have not been disclosed publicly. However, Phoreus Biotechnology has achieved significant milestones in developing its proprietary platforms, positioning itself as a leader in the field of precision drug delivery. The impact of their technology promises to advance genetic technology and improve global health outcomes by providing more effective and targeted therapeutic solutions.

Phoreus Biotechnology - Similar Companies

PhagePro logo

PhagePro

phageproinc.com

Aphios logo

Aphios

aphios.com

PepVax logo

PepVax

pepvax.co

Cytonus Therapeutics logo

Cytonus Therapeutics

cytonus.com

Extend Biosciences logo

Extend Biosciences

extendbio.com

Phoresa logo

Phoresa

PhageTech logo

PhageTech

phagetech.com

Aera Therapeutics logo

Aera Therapeutics

aeratx.com

Atom Bioworks logo

Atom Bioworks

atombioworks.com

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Nano RED logo

Nano RED

Souvie Biodelivery logo

Souvie Biodelivery

SmartPhage logo

SmartPhage

pH Pharma logo

pH Pharma

ph-pharma.com

Syntis Bio logo

Syntis Bio

syntis.bio

Phoreus Biotechnology - Quick Facts

Who are Phoreus Biotechnology's competitors?

Companies similar to Phoreus Biotechnology include PhagePro, Aphios, PepVax and Cytonus Therapeutics.

When was Phoreus Biotechnology founded?

Phoreus Biotechnology was founded in 2018.

Where is Phoreus Biotechnology's headquarters located?

Phoreus Biotechnology's headquarters is located in Olathe, KS, US.

When was Phoreus Biotechnology's last funding round?

Phoreus Biotechnology's most recent funding round was for $2.3M (USD) in May 2022.

How much has Phoreus Biotechnology raised to-date?

As of May 11, 2022, Phoreus Biotechnology has raised a total of $3.1M (USD).

How many employees does Phoreus Biotechnology have?

Phoreus Biotechnology has 5 employees as of Feb 5, 2024.

Phoreus Biotechnology - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified